| The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro D Ghosh, M Mondal, GM Mohite, PK Singh, P Ranjan, A Anoop, S Ghosh, ... Biochemistry 52 (40), 6925-6927, 2013 | 223 | 2013 |
| p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis S Ghosh, S Salot, S Sengupta, A Navalkar, D Ghosh, R Jacob, S Das, ... Cell Death & Differentiation 24 (10), 1784-1798, 2017 | 124 | 2017 |
| Elucidating the Role of Disulfide Bond on Amyloid Formation and Fibril Reversibility of Somatostatin-14: RELEVANCE TO ITS STORAGE AND SECRETION*♦ A Anoop, S Ranganathan, BD Dhaked, NN Jha, S Pratihar, S Ghosh, ... Journal of Biological Chemistry 289 (24), 16884-16903, 2014 | 83 | 2014 |
| Amyloid formation of growth hormone in presence of zinc: Relevance to its storage in secretory granules RS Jacob, S Das, S Ghosh, A Anoop, NN Jha, T Khan, P Singru, A Kumar, ... Scientific reports 6 (1), 23370, 2016 | 79 | 2016 |
| Prion-like p53 amyloids in cancer A Navalkar, S Ghosh, S Pandey, A Paul, D Datta, SK Maji Biochemistry 59 (2), 146-155, 2019 | 59 | 2019 |
| Investigating the intrinsic aggregation potential of evolutionarily conserved segments in p53 S Ghosh, D Ghosh, S Ranganathan, A Anoop, SK P, NN Jha, ... Biochemistry 53 (38), 5995-6010, 2014 | 59 | 2014 |
| Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption PW Janowicz, ZH Houston, J Bunt, NL Fletcher, CA Bell, G Cowin, ... Biomaterials 283, 121416, 2022 | 17 | 2022 |
| Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance NL Fletcher, A Prior, O Choy, J Humphries, P Huda, S Ghosh, ZH Houston, ... Chemical Communications 58 (57), 7912-7915, 2022 | 11 | 2022 |
| Antiviral activity of rosmarinic acid against four serotypes of dengue virus R Panchal, S Ghosh, R Mehla, J Ramalingam, S Gairola, S Mukherjee, ... Current Microbiology 79 (7), 203, 2022 | 8 | 2022 |
| Assembly of Bacillus subtilis FtsA: Effects of pH, ionic strength and nucleotides on FtsA assembly P Singh, RD Makde, S Ghosh, J Asthana, V Kumar, D Panda International journal of biological macromolecules 52, 170-176, 2013 | 6 | 2013 |
| Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma S Ghosh, NL Fletcher, P Huda, ZH Houston, CB Howard, ME Lund, Y Lu, ... Molecular pharmaceutics 20 (3), 1549-1563, 2023 | 5 | 2023 |
| Clinical development of an anti-GPC-1 antibody for the treatment of cancer S Ghosh, P Huda, N Fletcher, D Campbell, KJ Thurecht, B Walsh Expert Opinion on Biological Therapy 22 (5), 603-613, 2022 | 4 | 2022 |
| Antibody-based formats to target glioblastoma: overcoming barriers to protein drug delivery S Ghosh, P Huda, NL Fletcher, CB Howard, B Walsh, D Campbell, ... Molecular Pharmaceutics 19 (5), 1233-1247, 2022 | 2 | 2022 |
| RAFT Polymer–Antibody Conjugation: Squaramide Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody with Full Retention of Activity and Increased Tumor … A Ardana, S Ghosh, P Huda, NL Fletcher, KJ Thurecht, CC Williams Molecular Pharmaceutics 20 (6), 3073-3087, 2023 | 1 | 2023 |
| A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements JL Wood, S Ghosh, ZH Houston, NL Fletcher, J Humphries, K Mardon, ... Chemical Science 15 (30), 11748-11760, 2024 | | 2024 |
| Novel antibody theranostics for oncology S Ghosh | | 2023 |
| Immuno-PET agents for targeting glioblastoma S Ghosh, P Huda, N Fletcher, C Howard, Y Lu, D Campbell, B Walsh, ... Internal Medicine Journal 52 (Supplement 2), 24-24, 2022 | | 2022 |
